Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine

Overview of attention for article published in Cancer Immunology, Immunotherapy, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (82nd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter: 1 X user
patent: 3 patents

facebook: 1 Facebook page

Citations

dimensions_citation: 64 Dimensions

Readers on

mendeley: 70 Mendeley

Summary X Patents Facebook Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

Grant US-10729766-B2

United States of America

FIBROBLAST DELIVERY OF TUMOR INHIBITORY AGENTS

Application WO-2019213510-A1

World Intellectual Property Organisation (WIPO)

Method for improving the efficacy of a survivin vaccine in the treatment of cancer

Grant US-10022441-B2

United States of America